James Wells
Frazer Institute, QLD, Australia
- This delegate is presenting an abstract at this event.

James Wells is a Senior Research Fellow at The University of Queensland Diamantina Institute who leads a group devoted to studying mechanisms of CD8 T-cell regulation in skin and skin cancer. He is an immunologist with a particular interest in uncovering factors that promote the establishment and regression of cutaneous squamous cell carcinoma. He has discovered that CD8 T-cells critically prevent the emergence of squamous cell carcinoma, as well as contributing significantly to squamous cell carcinoma regression. The primary goal of his research is to discover new therapeutic interventions that will ‘switch on’ CD8 T-cell function within established skin cancer.
Presentations this author is a contributor to:
Development of an in vivo model to study the effects of monoclonal antibody treatment of squamous cell carcinoma (#247)
4:00 PM
Xuzhi (Jessica) He
Poster Session Two
Investigating the role of CD8 T-cells in Rapamycin-mediated regression of squamous cell carcinoma (#350)
4:00 PM
Nicola Pett
Poster Session Three
The role of CD8+ T-cells in the regression of Squamous Cell Carcinoma (#418)
4:00 PM
Zhen ZENG
Poster Session Three
CESTEM-1 clinical trials: using dynamin inhibitors to reverse resistance to monoclonal antibody therapy. (49404)
3:20 PM
Fiona Simpson
Tumour Immunology Workshop Session V: Translational Immunotherapy